Kuzhan O - Search Results

1

Survival benefit with GM-CSF use after high-dose chemotherapy in high-risk breast cancer.

Kuzhan O, Ozet A, Ulutin C, Kömürcü S, Arpaci F, Oztürk B, Oztürk M. Kuzhan O, et al. Tumori. 2007 Nov-Dec;93(6):550-6. doi: 10.1177/030089160709300606. Tumori. 2007. PMID: 18338488

2

Stem cell mobilization by G-CSF in solid and hematological malignancies: single daily dose is better than split dose in obese patients.

Cetin T, Arpaci F, Ozet A, Oztürk B, Kömürcü S, Ihsan Uzar A, Yilmaz I, Beyzadeoĝlu M, Oysul K, Ataergin S, Kuzhan O, Pekel A. Cetin T, et al. Among authors: kuzhan o. J Clin Apher. 2003;18(3):120-4. doi: 10.1002/jca.10068. J Clin Apher. 2003. PMID: 14569602

3

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.

Arpaci F, Ataergin S, Ozet A, Erler K, Basbozkurt M, Ozcan A, Komurcu S, Ozturk B, Celasun B, Kilic S, Kuzhan O. Arpaci F, et al. Among authors: kuzhan o. Cancer. 2005 Sep 1;104(5):1058-65. doi: 10.1002/cncr.21279. Cancer. 2005. PMID: 15999369 Free article. Clinical Trial.

4

Primary glioblastoma multiforme in younger patients: a single-institution experience.

Ulutin C, Fayda M, Aksu G, Cetinayak O, Kuzhan O, Ors F, Beyzadeoglu M. Ulutin C, et al. Among authors: kuzhan o. Tumori. 2006 Sep-Oct;92(5):407-11. doi: 10.1177/030089160609200507. Tumori. 2006. PMID: 17168433

5

Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients.

Kuzhan O, Ozet A, Ulutin C, Kurt B, Komurcu S, Ozturk B, Ataergin S, Gunhan O. Kuzhan O, et al. Saudi Med J. 2007 Sep;28(9):1374-9. Saudi Med J. 2007. PMID: 17768463

6

The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high-dose chemotherapy in patients with Stage III breast cancer.

Arpaci F, Safali M, Ozet A, Ural AU, Cetin T, Ozturk M, Ataergin S, Kuzhan O, Komurcu S, Ozturk B, Acikel C. Arpaci F, et al. Among authors: kuzhan o. J Clin Apher. 2009;24(5):197-204. doi: 10.1002/jca.20211. J Clin Apher. 2009. PMID: 19816961 Clinical Trial.

7

The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS.

Arpaci F, Cetin T, Ozet A, Oysul K, Pekel A, Ataergin S, Kuzhan O, Kömürcü S, Oztürk B. Arpaci F, et al. Among authors: kuzhan o. J Clin Apher. 2004;19(4):197-201. doi: 10.1002/jca.20029. J Clin Apher. 2004. PMID: 15597344

8

G-CSF-mobilized haploidentical peripheral blood stem cell transplantation in children with poor prognostic nonmalignant disorders.

Arpaci F, Tezcan I, Kuzhan O, Yalman N, Uckan D, Kürekci AE, Ikincioğullari A, Ozet A, Tanyeli A. Arpaci F, et al. Among authors: kuzhan o. Am J Hematol. 2008 Feb;83(2):133-6. doi: 10.1002/ajh.21017. Am J Hematol. 2008. PMID: 17722073 Free article.

9

Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.

Ozturk M, Komurcu S, Kilic S, Ozet A, Arpaci F, Ozturk B, Kuzhan O, Ataergin S. Ozturk M, et al. Among authors: kuzhan o. Support Care Cancer. 2009 Oct;17(10):1295-9. doi: 10.1007/s00520-009-0586-6. Epub 2009 Feb 6. Support Care Cancer. 2009. PMID: 19198890

10

Isolated renal relapse of a case with non-Hodgkin's lymphoma.

Turk HM, Ozet A, Ozturk M, Komurcu S, Kuzhan O, Arpaci F, Ozturk B, Safali M. Turk HM, et al. Among authors: kuzhan o. Med Oncol. 2010 Jun;27(2):434-8. doi: 10.1007/s12032-009-9229-5. Epub 2009 May 13. Med Oncol. 2010. PMID: 19437146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters